Non-hepatic Cancers Independently Predict Liver Decompensation Events
- 13 May 2020
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 52 (2) , 523-528
Abstract
Background Advanced liver fibrosis and cirrhosis represent independent risk factors for hepatocellular carcinoma (HCC). There is also evidence suggesting that several etiologies of chronic liver disease elevate the risk for non-hepatic cancers, including nonalcoholic fatty liver disease (NAFLD), alcohol abuse, and hepatitis C infection. In the present study, we aim to characterize the cancer incidence in patients with chronic liver disease and assess the prognostic value of non-hepatic cancer on the decompensation events of this population. Methods We retrospectively reviewed the electronic medical records of patients who underwent transient elastography (TE) of liver, at John H. Stroger Hospital in Cook County, Chicago, IL. We identified patients who had decompensation of cirrhosis. We also extracted their cancer history. The cancer profiles of the cohort were compared by the presence or absence of advanced liver fibrosis. We then performed univariate and multivariate forward stepwise Cox regression analysis to identify the significant risk factors for the decompensation events and plotted Kaplan-Meier curve to demonstrate the significance of cancer in the prediction of decompensation events. Results We identified a total of 3097 patients who underwent TE. A total of 45 liver decompensation events were documented. In the univariate Cox regression model, MELD-Na score (hazard ratio (HR) 1.25, p < 0.001), liver stiffness measurement (HR 1.05, p = 0.004), and history of any cancer (HR 3.81, p = 0.001) emerged as predictors of decompensation. Non-hepatic cancer proved to be a significant predictor of decompensation (HR 3.57, p = 0.002). Conclusion The present study represents the first attempt to the best of our knowledge to describe the cancer incidence in this high-risk population. We found that non-HCC cancers independently predict hepatic decompensation events, which is an intriguing finding. We propose that physicians should be more vigilant to cancer history of patients with chronic liver disease as it might provide valuable prognostic information and guide individualized treatment and surveillance plans.Keywords
This publication has 13 references indexed in Scilit:
- Increased cancer rates in patients with chronic hepatitis CLiver International, 2019
- Non-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersInternational Journal of Molecular Sciences, 2016
- Gut microbiota and host metabolism in liver cirrhosisWorld Journal of Gastroenterology, 2015
- Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysisBritish Journal of Cancer, 2014
- Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2013
- Increased Risk for Malignant Neoplasms Among Patients With CirrhosisClinical Gastroenterology and Hepatology, 2011
- Value of transient elastography for the prediction of variceal bleedingWorld Journal of Gastroenterology, 2011
- Alcohol and cancerThe Lancet Oncology, 2006
- Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis CGastroenterology, 2005
- Risk of Cancer in Patients Hospitalized With Fatty LiverJournal of Clinical Gastroenterology, 2003